Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2003-4-22
pubmed:abstractText
Positive transcription factor b (P-TEFb) is required for RNA polymerase II to make the transition from abortive to productive elongation. This important factor is a heterodimer of a cyclin-dependent kinase, cyclin-dependent kinase 9 (Cdk9), and one of four cyclin partners, cyclin T1, T2a, T2b or K. We demonstrate here that there exists in cells a second form of Cdk9 that is 13 kDa larger than the protein originally identified. Both of these forms, which we name Cdk9(42) and Cdk9(55), are present in HeLa and NIH/3T3 cells. Cdk9(55) is generated from an mRNA that originates from a second promoter located upstream of the startpoint of transcription used to generate mRNAs encoding Cdk9(42). Antibodies specific for Cdk9(55) immunoprecipitate Cdk(55) and cyclin T1, but not Cdk9(42). Cdk9(55) in the immunoprecipitates is active as judged by its ability to phosphorylate the carboxyl-terminal domain of the largest subunit of RNA polymerase II. Recently it has been shown that the activity of P-TEFb is negatively regulated in cells by reversible association with a small cellular RNA called 7SK. We show here that P-TEFb molecules containing either form of Cdk9 are found in association with 7SK and both complexes are disrupted by treatment with 600 mM KCl. The relative abundance of Cdk9(55) and Cdk9(42) changes in different cell types, including HeLa, NIH/3T3, human macrophages and mouse lung tissue. Additionally, treatment of macrophages with lipopolysaccharides or infection with human immunodeficiency virus alters the relative abundance of the two forms of Cdk9.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0378-1119
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
307
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-82
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12706900-3T3 Cells, pubmed-meshheading:12706900-Alternative Splicing, pubmed-meshheading:12706900-Amino Acid Sequence, pubmed-meshheading:12706900-Animals, pubmed-meshheading:12706900-Blotting, Western, pubmed-meshheading:12706900-Cells, Cultured, pubmed-meshheading:12706900-Cyclin-Dependent Kinase 9, pubmed-meshheading:12706900-Cyclin-Dependent Kinases, pubmed-meshheading:12706900-Gene Expression, pubmed-meshheading:12706900-HeLa Cells, pubmed-meshheading:12706900-Humans, pubmed-meshheading:12706900-Isoenzymes, pubmed-meshheading:12706900-Lung, pubmed-meshheading:12706900-Macrophages, pubmed-meshheading:12706900-Male, pubmed-meshheading:12706900-Mice, pubmed-meshheading:12706900-Mice, Inbred C57BL, pubmed-meshheading:12706900-Molecular Sequence Data, pubmed-meshheading:12706900-RNA, Messenger, pubmed-meshheading:12706900-Sequence Homology, Amino Acid
pubmed:year
2003
pubmed:articleTitle
Identification of a novel isoform of Cdk9.
pubmed:affiliation
Department of Biochemistry, University of Iowa, Iowa City, IA 52242, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.